Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation

NCT05866796 is registered in ClinicalTrials.gov with University Hospital, Ghent as lead sponsor.

NCT NCT05866796
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05866796 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation
Lead sponsor
University Hospital, Ghent
Phase
Observational
Overall status
Recruiting
Start date
April 26, 2023
Completion date
March 31, 2028
Enrollment
600 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver transplant failure, prognostic biomarkers